189 related articles for article (PubMed ID: 15288088)
21. Sildenafil as a selective pulmonary vasodilator in childhood primary pulmonary hypertension.
Abrams D; Schulze-Neick I; Magee AG
Heart; 2000 Aug; 84(2):E4. PubMed ID: 10908271
[TBL] [Abstract][Full Text] [Related]
22. Long-term sildenafil added to intravenous epoprostenol in patients with pulmonary arterial hypertension.
Simonneau G; Rubin LJ; Galiè N; Barst RJ; Fleming TR; Frost A; Engel P; Kramer MR; Serdarevic-Pehar M; Layton GR; Sitbon O; Badesch DB;
J Heart Lung Transplant; 2014 Jul; 33(7):689-97. PubMed ID: 24815795
[TBL] [Abstract][Full Text] [Related]
23. Successful up-front combination therapy in a patient with idiopathic pulmonary hypertension and patent foramen ovale: an alternative to epoprostenol therapy?
Pitsiou GG; Chavouzis N; Nakou C; Boutou AK; Argyropoulou P; Stanopoulos I
J Heart Lung Transplant; 2009 Jun; 28(6):651-3. PubMed ID: 19481029
[TBL] [Abstract][Full Text] [Related]
24. Combination therapy with sildenafil and bosentan reverts severe pulmonary hypertension and allows heart transplantation: case report.
Mogollón MV; Lage E; Cabezón S; Hinojosa R; Ballesteros S; Aranda A; Sobrino JM; Ordóñez A
Transplant Proc; 2006 Oct; 38(8):2522-3. PubMed ID: 17097987
[TBL] [Abstract][Full Text] [Related]
25. Marked improvement with sildenafil in a patient with primary pulmonary hypertension unresponsive to epoprostenol.
Kataoka M; Satoh T; Manabe T; Anzai T; Yoshikawa T; Mitamura H; Ogawa S
Intern Med; 2004 Oct; 43(10):945-50. PubMed ID: 15575245
[TBL] [Abstract][Full Text] [Related]
26. Addition of sildenafil to bosentan monotherapy in pulmonary arterial hypertension.
Mathai SC; Girgis RE; Fisher MR; Champion HC; Housten-Harris T; Zaiman A; Hassoun PM
Eur Respir J; 2007 Mar; 29(3):469-75. PubMed ID: 17079256
[TBL] [Abstract][Full Text] [Related]
27. Endothelin receptor expression in idiopathic pulmonary arterial hypertension: effect of bosentan and epoprostenol treatment.
Hall SM; Davie N; Klein N; Haworth SG
Eur Respir J; 2011 Oct; 38(4):851-60. PubMed ID: 21406517
[TBL] [Abstract][Full Text] [Related]
28. [The treatment of idiopathic pulmonary artery hypertension and its relation to systemic scleroderma].
Humbert M
Rev Med Interne; 2007 Dec; 28 Suppl 4():S273-6. PubMed ID: 17961866
[No Abstract] [Full Text] [Related]
29. [Treatment of pulmonary arterial hypertension].
Montani D; Sitbon O; Jaïs X; Cabrol S; Simonneau G; Humbert M
Presse Med; 2005 Nov; 34(19 Pt 2):1445-55. PubMed ID: 16301976
[TBL] [Abstract][Full Text] [Related]
30. Sildenafil treatment of primary pulmonary hypertension.
Laupland KB; Helmersen D; Zygun DA; Viner SM
Can Respir J; 2003; 10(1):48-50. PubMed ID: 12624621
[TBL] [Abstract][Full Text] [Related]
31. [Efficacy of oral sildenafil as rescue therapy in patients with severe pulmonary arterial hypertension chronically treated with prostacyclin. Long-term results].
Jiménez López-Guarch C; Escribano Subias P; Tello de Meneses R; Delgado Jiménez JF; Sadia Pérez D; Velázquez Martín MT; Gómez Sánchez MA; Sáenz de la Calzada C
Rev Esp Cardiol; 2004 Oct; 57(10):946-51. PubMed ID: 15469792
[TBL] [Abstract][Full Text] [Related]
32. [The combined use of sildenafil with epoprostenol in a patient with primary pulmonary hypertension].
Kayikçioğlu M; Can LH; Payzin S; Kültürsay H; Soydan I
Anadolu Kardiyol Derg; 2002 Sep; 2(3):262-4. PubMed ID: 12223337
[No Abstract] [Full Text] [Related]
33. [Treatment of pulmonary arterial hypertension].
Jaïs X; Bonnet D
Presse Med; 2010 Jun; 39 Suppl 1():1S22-32. PubMed ID: 20732614
[TBL] [Abstract][Full Text] [Related]
34. [Combined treatment with intravenous prostacyclin and sildenafil in patients with pulmonary hypertension: report of 4 cases].
García Hernández FJ; Ocaña Medina C; Mateos Romero L; Martínez Martínez A; Bautista Lorite A; Santos Ramos B; Sánchez Román J
Med Clin (Barc); 2004 Jan; 122(2):64-6. PubMed ID: 14733859
[TBL] [Abstract][Full Text] [Related]
35. Pulmonary arterial hypertension: the race for the most effective treatment.
McLaughin VV; Hoeper MM
Am J Respir Crit Care Med; 2005 Jun; 171(11):1199-201. PubMed ID: 15914567
[No Abstract] [Full Text] [Related]
36. Emerging medical therapies for pulmonary arterial hypertension.
Galiè N; Manes A; Branzi A
Prog Cardiovasc Dis; 2002; 45(3):213-24. PubMed ID: 12525997
[TBL] [Abstract][Full Text] [Related]
37. Safety and efficacy of transition from subcutaneous treprostinil to oral sildenafil in patients with pulmonary arterial hypertension.
Keogh AM; Jabbour A; Weintraub R; Brown K; Hayward CS; Macdonald PS
J Heart Lung Transplant; 2007 Nov; 26(11):1079-83. PubMed ID: 18022071
[TBL] [Abstract][Full Text] [Related]
38. Pharmacologic treatment for pulmonary arterial hypertension.
Sastry BK
Curr Opin Cardiol; 2006 Nov; 21(6):561-8. PubMed ID: 17053404
[TBL] [Abstract][Full Text] [Related]
39. Safety and tolerability of targeted therapies for pulmonary hypertension in children.
Roldan T; Deiros L; Romero JA; Gutierrez-Larraya F; Herrero A; Del Cerro MJ
Pediatr Cardiol; 2014 Mar; 35(3):490-8. PubMed ID: 24141893
[TBL] [Abstract][Full Text] [Related]
40. Assessment and treatment of pulmonary arterial hypertension: an Australian perspective in 2006.
Gabbay E; Reed A; Williams TJ
Intern Med J; 2007 Jan; 37(1):38-48. PubMed ID: 17199843
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
